PositiveID Selected to Present and Exhibit at the 2015 Military Health System Research Symposium August 17-20 DELRAY BEACH, Fla., Aug. 10, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, announced...

PositiveID and GenArraytion Partner on Firefly Dx DELRAY BEACH, Fla., Aug. 04, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, and...

PositiveID Updates Shareholders on Goals for the Second Half of 2015 DELRAY BEACH, Fla., July 28, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today...

PositiveID Provides Mid-Year Update and Highlights Its Progress With Firefly Dx Development DELRAY BEACH, Fla., June 29, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, provided a...

PositiveID Corporation Awarded U.S. Patent No. 8,133,451 for First-of-Its-Kind Detection System for Molecular Biological Diagnostics DELRAY BEACH, Fla., March 20, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCBB:PSID), an emerging growth company and developer of advanced technologies for diabetes management as...